171 related articles for article (PubMed ID: 21147219)
21. Kinetics of degradation and oil solubility of ester prodrugs of a model dipeptide (Gly-Phe).
Larsen SW; Ankersen M; Larsen C
Eur J Pharm Sci; 2004 Aug; 22(5):399-408. PubMed ID: 15265509
[TBL] [Abstract][Full Text] [Related]
22. A quantitative structure-activity relationship for translocation of tripeptides via the human proton-coupled peptide transporter, hPEPT1 (SLC15A1).
Omkvist DH; Larsen SB; Nielsen CU; Steffansen B; Olsen L; Jørgensen FS; Brodin B
AAPS J; 2010 Sep; 12(3):385-96. PubMed ID: 20449699
[TBL] [Abstract][Full Text] [Related]
23. Cellular uptake mechanism of amino acid ester prodrugs in Caco-2/hPEPT1 cells overexpressing a human peptide transporter.
Han HK; Oh DM; Amidon GL
Pharm Res; 1998 Sep; 15(9):1382-6. PubMed ID: 9755889
[TBL] [Abstract][Full Text] [Related]
24. Application of enzymatically stable dipeptides for enhancement of intestinal permeability. Synthesis and in vitro evaluation of dipeptide-coupled compounds.
Friedrichsen GM; Jakobsen P; Taub M; Begtrup M
Bioorg Med Chem; 2001 Oct; 9(10):2625-32. PubMed ID: 11557350
[TBL] [Abstract][Full Text] [Related]
25. Prodrugs of purine and pyrimidine analogues for the intestinal di/tri-peptide transporter PepT1: affinity for hPepT1 in Caco-2 cells, drug release in aqueous media and in vitro metabolism.
Thomsen AE; Friedrichsen GM; Sørensen AH; Andersen R; Nielsen CU; Brodin B; Begtrup M; Frokjaer S; Steffansen B
J Control Release; 2003 Jan; 86(2-3):279-92. PubMed ID: 12526824
[TBL] [Abstract][Full Text] [Related]
26. Molecular interactions between dipeptides, drugs and the human intestinal H+ -oligopeptide cotransporter hPEPT1.
Sala-Rabanal M; Loo DD; Hirayama BA; Turk E; Wright EM
J Physiol; 2006 Jul; 574(Pt 1):149-66. PubMed ID: 16627568
[TBL] [Abstract][Full Text] [Related]
27. Uptake of cyclic dipeptide by PEPT1 in Caco-2 cells: phenolic hydroxyl group of substrate enhances affinity for PEPT1.
Mizuma T; Narasaka T; Awazu S
J Pharm Pharmacol; 2002 Sep; 54(9):1293-6. PubMed ID: 12356285
[TBL] [Abstract][Full Text] [Related]
28. A peptide prodrug approach for improving bisphosphonate oral absorption.
Ezra A; Hoffman A; Breuer E; Alferiev IS; Mönkkönen J; El Hanany-Rozen N; Weiss G; Stepensky D; Gati I; Cohen H; Törmälehto S; Amidon GL; Golomb G
J Med Chem; 2000 Oct; 43(20):3641-52. PubMed ID: 11020278
[TBL] [Abstract][Full Text] [Related]
29. The tandem chain extension aldol reaction used for synthesis of ketomethylene tripeptidomimetics targeting hPEPT1.
Thorn K; Nielsen CU; Jakobsen P; Steffansen B; Zercher CK; Begtrup M
Bioorg Med Chem Lett; 2011 Aug; 21(15):4597-601. PubMed ID: 21703856
[TBL] [Abstract][Full Text] [Related]
30. Constrained H-Phe-Phe-NH2 analogues with high affinity to the substance P 1-7 binding site and with improved metabolic stability and cell permeability.
Fransson R; Sköld C; Kratz JM; Svensson R; Artursson P; Nyberg F; Hallberg M; Sandström A
J Med Chem; 2013 Jun; 56(12):4953-65. PubMed ID: 23735006
[TBL] [Abstract][Full Text] [Related]
31. Effects of amino acid chirality and the chemical linker on the cell permeation characteristics of cyclic prodrugs of opioid peptides.
Liederer BM; Fuchs T; Vander Velde D; Siahaan TJ; Borchardt RT
J Med Chem; 2006 Feb; 49(4):1261-70. PubMed ID: 16480263
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics of novel dipeptide ester prodrugs of acyclovir after oral administration: intestinal absorption and liver metabolism.
Anand BS; Katragadda S; Mitra AK
J Pharmacol Exp Ther; 2004 Nov; 311(2):659-67. PubMed ID: 15226381
[TBL] [Abstract][Full Text] [Related]
33. The in vitro transport of model thiodipeptide prodrugs designed to target the intestinal oligopeptide transporter, PepT1.
Foley D; Pieri M; Pettecrew R; Price R; Miles S; Lam HK; Bailey P; Meredith D
Org Biomol Chem; 2009 Sep; 7(18):3652-6. PubMed ID: 19707666
[TBL] [Abstract][Full Text] [Related]
34. Epidermal growth factor and insulin short-term increase hPepT1-mediated glycylsarcosine uptake in Caco-2 cells.
Nielsen CU; Amstrup J; Nielsen R; Steffansen B; Frokjaer S; Brodin B
Acta Physiol Scand; 2003 Jun; 178(2):139-48. PubMed ID: 12780388
[TBL] [Abstract][Full Text] [Related]
35. Beta- and gamma-di- and tripeptides as potential substrates for the oligopeptide transporter hPepT1.
Hubatsch I; Arvidsson PI; Seebach D; Luthman K; Artursson P
J Med Chem; 2007 Oct; 50(21):5238-42. PubMed ID: 17887660
[TBL] [Abstract][Full Text] [Related]
36. CHO/hPEPT1 cells overexpressing the human peptide transporter (hPEPT1) as an alternative in vitro model for peptidomimetic drugs.
Han HK; Rhie JK; Oh DM; Saito G; Hsu CP; Stewart BH; Amidon GL
J Pharm Sci; 1999 Mar; 88(3):347-50. PubMed ID: 10052994
[TBL] [Abstract][Full Text] [Related]
37. Convenient synthesis of Ibuprofen and naproxen aminoacyl, dipeptidoyl and ester derivatives.
Katritzky AR; Jishkariani D; Narindoshvili T
Chem Biol Drug Des; 2009 Jun; 73(6):618-26. PubMed ID: 19635053
[TBL] [Abstract][Full Text] [Related]
38. Membrane topology of the human dipeptide transporter, hPEPT1, determined by epitope insertions.
Covitz KM; Amidon GL; Sadée W
Biochemistry; 1998 Oct; 37(43):15214-21. PubMed ID: 9790685
[TBL] [Abstract][Full Text] [Related]
39. Transport of the advanced glycation end products alanylpyrraline and pyrralylalanine by the human proton-coupled peptide transporter hPEPT1.
Geissler S; Hellwig M; Zwarg M; Markwardt F; Henle T; Brandsch M
J Agric Food Chem; 2010 Feb; 58(4):2543-7. PubMed ID: 20104847
[TBL] [Abstract][Full Text] [Related]
40. Design, synthesis, and metal binding of novel Pseudo- oligopeptides containing two phosphinic acid groups.
Ye Y; Liu M; Kao JL; Marshall GR
Biopolymers; 2008 Jan; 89(1):72-85. PubMed ID: 17910046
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
